One important metric to look for in a stock is an 80 or higher Relative Strength Rating. National Health Investors cleared that benchmark Monday, with a jump from 76 to 82 Monday.
IBD's unique rating measures price performance with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the trailing 52 weeks holds up against all the other stocks in our database.
History shows that the market's biggest winners often have an RS Rating of at least 80 in the early stages of their moves.
Risk Management In The Stock Market: How Much Money To Invest Now
National Health Investors is trying to complete a double bottom with an 82.32 buy point. See if the stock can clear the breakout price in heavy trade.
National Health Investors saw both earnings and sales growth rise last quarter. Earnings-per-share increased from -5% to 3%. Revenue rose from 4% to 8%.
The company earns the No. 31 rank among its peers in the Finance-Property REITs industry group. CareTrust REIT, Essex Property Trust and Curbline Properties are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
